Navigation Links
Palatin Technologies, Inc. Issued U.S. Patent for Heart Failure Drug Candidate
Date:12/1/2009

. PL-3994 has an extended half-life, with reduced affinity for natriuretic peptide clearance receptors and increased resistance to neutral endopeptidase, an endogenous enzyme that degrades natriuretic peptides. The result is a drug candidate with improved pharmacokinetic and pharmacodynamic properties.

About Heart Failure

Heart failure affects over 5.7 million people in the United States, with 670,000 new cases diagnosed each year. Despite the treatment of heart failure with multiple drugs, the prognosis remains poor. There were over 1.1 million hospitalizations for heart failure in 2006 in the United States, with estimated direct and indirect costs of heart failure in the United States for 2009 of $37.2 billion.

About Palatin Technologies, Inc.

Palatin Technologies, Inc. is a biopharmaceutical company focused on discovering and developing targeted, receptor-specific small molecule and peptide therapeutics. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders in order to maximize their commercial potential. For additional information regarding Palatin, please visit Palatin Technologies' website at www.palatin.com.

Forward-looking Statements

Statements about future expectations of Palatin Technologies, Inc., including statements about its development programs, proposed indications for its product candidates, pre-clinical activities, marketing collaborations, and all other statements in this document other than historical facts, are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and as that term is defined in the Private Securities Litigation Reform Act of 1995. Palatin intends that such forward-looking statements be subject to the safe harbors created thereb
'/>"/>

SOURCE Palatin Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2010 Results; Teleconference and Webcast to be held on November 16, 2009
2. Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2009 Results; Teleconference and Webcast to be held on September 8, 2009
3. Palatin Technologies, Inc. to Report Fourth Quarter and Fiscal Year 2009 Results; Teleconference and Webcast to be held on September 8, 2009
4. Palatin Technologies to Present at the Rodman & Renshaw 11th Annual Global Investment Conference
5. Palatin Technologies, Inc. to Raise $3.1 Million in Registered Direct Offering
6. Palatin Technologies, Inc. Reports Positive Bremelanotide Study; Improved Safety Profile with Subcutaneous Administration
7. Palatin Technologies, Inc. Receives U.S. Patent Allowance for Heart Failure Drug Candidate
8. Palatin Technologies Listing Compliance Plan Accepted by NYSE Alternext US
9. Palatin Technologies to Report Fiscal Year 2009 Second Quarter Results; Conference Call and Webcast on February 17, 2009
10. Palatin Technologies Receives Notification Letter from NYSE Alternext US
11. Palatin Technologies to Report Fiscal Year 2009 First Quarter Results; Conference Call and Webcast on November 17, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/13/2014)... USA, and TAICHUNG, Taiwan (PRWEB) December 12, 2014 ... despite less rosy indicators in overall global economic growth, ... for optics and photonics , said in a featured ... Conference) on 5 December at the National Chung Hsing ... energy, which is being integrated into future energy supplies ...
(Date:12/13/2014)... December 13, 2014 According to population ... people between now and 2030." If a population explosion ... seventh most populous state in the country. , To ... at the Future of North Carolina Forum on December ... we have the necessary infrastructure in place? Enough clean ...
(Date:12/13/2014)... , Dec. 12, 2014  Vermillion, Inc. (NasdaqCM: VRML), ... today the appointments of Veronica G. H. Jordan ... the Company,s Board of Directors, bringing the total number ... Jim LaFrance , Chairman, President, ... tremendously pleased to announce the appointments of Veronica and ...
(Date:12/13/2014)... N.Y. , Dec. 12, 2014 /PRNewswire/ ... in the discovery and development of therapeutic ... diseases, today announced publication of a manuscript ... and inhibits remyelination in neurodegenerative disease" in ... Neurobiology of Disease*.  The publication highlights an ...
Breaking Biology Technology:Photonics Continues Upward Trends Despite Challenges in the Global Economy, Notes SPIE CEO 2Photonics Continues Upward Trends Despite Challenges in the Global Economy, Notes SPIE CEO 3Photonics Continues Upward Trends Despite Challenges in the Global Economy, Notes SPIE CEO 4Photonics Continues Upward Trends Despite Challenges in the Global Economy, Notes SPIE CEO 5North Carolina Chamber of Commerce: Asking Questions & Gathering Answers with a Futurist 2Vermillion Strengthens Board of Directors with Appointments of Veronica Jordan, Ph.D., and David Schreiber 2Vermillion Strengthens Board of Directors with Appointments of Veronica Jordan, Ph.D., and David Schreiber 3Vaccinex announces publication of preclinical studies with an anti-SEMA4D antibody in animal models of neuroinflammatory and demyelinating disease 2
... MultiCell,Technologies, Inc. (OTC Bulletin Board: MCET) has moved into new ... May 1, 2008:, -- the new address is: ... RI 02895. -- new phone number is: ... (401) 762-0098, MultiCell Technologies, Inc. is a biopharmaceutical company ...
... to announce that,Grace Ju, Ph.D., research director, RNA Therapeutics ... of Science" by the New Jersey,Association of Biomedical Research ... held May 1 at the Bridgewater Manor., Dr. ... event, which is also,marking the 20th anniversary of NJABR, ...
... Company with 3 divisions has exciting new and unique products; ... contracts to be announced in near future ..., BOCA ... "Company") announced today that their stock is now,up and trading on ... Filings are complete at PinkSheets.com. From this point,Solei will continue on ...
Cached Biology Technology:MultiCell Technologies Relocates Corporate Headquarters 2Roche Research Director Grace Ju Hailed as NJABR 'Outstanding Woman of Science' 2Roche Research Director Grace Ju Hailed as NJABR 'Outstanding Woman of Science' 3Solei Systems, Inc., Announces That the Company Is Now Publicly Traded 2Solei Systems, Inc., Announces That the Company Is Now Publicly Traded 3Solei Systems, Inc., Announces That the Company Is Now Publicly Traded 4
(Date:11/18/2014)... --  News Highlights: , ... Partners Data Lake, an agile data and analytics ... allow researcher and clinicians to explore and develop ... of patients , The Partners Data Lake ... Partners system, breaking down physical barriers for collaboration ...
(Date:11/18/2014)... YORK , Nov. 18, 2014   ... identity authentication solutions, and MorphoTrust USA ... and services, today announced a strategic partnership to ... enterprise, motor vehicle administration (MVA), airport screening and ... in identity-related solutions, MorphoTrust serves consumers through a ...
(Date:11/12/2014)... 12, 2014 Crossmatch™, a leading provider of ... ® fingerprint readers have been deployed throughout Montparnasse ... Central Mexico . The bakery chain implemented the ... issues caused by employees clocking in for each other. ... readers, Montparnasse relied on paper timecards and a mechanical ...
Breaking Biology News(10 mins):Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 2Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 3Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 4Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 5EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 2EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 3Montparnasse Pasteleria Achieves Time and Attendance Transparency with Crossmatch U.are.U Fingerprint Readers 2
... Paul the Octopusthe eight-legged oracle who made international ... talented cephalopod in the sea. The Indonesian mimic octopus, ... potential predators, may well give Paul a run for ... By creatively configuring its limbs, adopting characteristic undulating movements, ...
... biology of a gecko,s sticky foot to create a robot ... scale a wall of slick glass, the Stickybot can climb ... gecko toes. , Mark Cutkosky, the lead designer of the ... Center for Design Research, has been collaborating with scientists around ...
... is urgently needed in Northern Ireland to ensure the ... researchers at Queen,s University Belfast. Lizards are found ... but a Queen,s study, published in international journal ... been replaced through agricultural intensification. "The fact that ...
Cached Biology News:Octopus mimics flatfish and flaunts it 2Octopus mimics flatfish and flaunts it 3Secrets of the gecko foot help robot climb 2Secrets of the gecko foot help robot climb 3No lounge for local lizards as living room vanishes 2
Screening test for the detection of Salmonella sp. by means of DNA amplification, subsequent molecular hybridization and detection on a microtitre plate....
... three step procedure (PCR, Exonuclease III digestion ... one day. The typical cloning efficiency using ... Features and Benefits: , , Universal - ... expression vector , High Cloning Efficiency - ...
... or 384-well PCR plates Dimples on both sides ... plates End tabs on Thermo-Mat™ 384 fit into ... sealing is achieved with either Thermo-Mat™ 96 or 384 ... lid thermal cyclers Fully autoclavable May ...
... HistoMark Biotin Streptavidin-HRP Systems provide rapid, ... intracellular antigens in frozen or paraffin-embedded ... These systems also facilitate double or ... be performed simultaneously with primary antibodies ...
Biology Products: